Contributors
-
TwentyTwentyTweets
Tweets by 2020health-
Join 7,195 other subscribers
-
Recent Posts
Pages
Category Archives: Research
Fatigue after stroke: so common, yet so little understood
Guest blog by Dr Shamim Quadir, Research Communications Manager at the Stroke Association For many reasons, we can all experience the normal type of fatigue that will usually resolve with rest. It could be due to a bad night’s sleep, or … Continue reading
Posted in Health and Wellbeing, Patients, Research, Stroke, Stroke Awareness Month, Work
Tagged Dr Anna Kuppuswamy, Dr Shamim Quadir, fatigue, Nottingham Fatigue After Stroke (NotFast), Sobell Department of Motor Neuroscienc, stroke, Stroke Association, University College London, University of Nottingham
Leave a comment
Weighing up the pros and cons of EU-funded research in stroke
Guest blog by Gary Randall, European Research Manager at the Stroke Association Horizon 2020 (H2020) is now up and running, and has funded its first new acute stroke project, PRECIOUS . The EU funding regulations enforce a multi-country, multi-culture approach … Continue reading
The next government must make high quality cancer care a priority during, and after, the upcoming general election
Guest Blog by Ellie Rose, Public Affairs Manager, Macmillan Cancer Support There are now 2.5 million people living with cancer in the UK. By 2020, this is estimated to rise to 3 million. And by the end of next year … Continue reading
Posted in Bowel Cancer, Breast Cancer, Cancer, Election, Public Health, Research, Social Care
Tagged cancer, CPES, end-of-life, General Election, Macmillan, NHS, Social Care
Leave a comment
British Heart Foundation and 2020health on the same page
2020health welcomes the latest report published by the British Heart Foundation (BHF) ‘The 21st Century Gingerbread House’. What particularly resonated with us where the two calls to action: • To protect children the UK Government should introduce consistent regulations across … Continue reading
Threats to Mankind from Drug Resistant Bacteria and Viruses
The risk of an end to the human race may sound like science fiction. However, there are only a small number of threats that could theoretically lead to the extinction of mankind. The four main concerns that most experts share … Continue reading
Posted in Business, David Cameron, Drugs, Global Health, GPs, International, Most Significant, NHS, Pharma, Public Health, Rare conditions, Research, Vaccination
Tagged 2020health, AIDS, amoxicillin, Antibacterial, antibiotics, antiviral, Augmentin, bacteria, bacterial susceptibility, beta-lactam, beta-lactamase, bureaucracy, carpenem, cephalosporin, Ebola, end of mankind, Gilead, hepatitis, Hospitals, Human, hygiene, isolation, monobactam, NICE, pathogen, penicillin, plague, PPRS, prescribing, prevention, Prime Minister, Pseudomonas, R & D, R&D, rabies, Research, Research and development, resistance, sofosbuvir, Sovaldi, vaccine, virus, WHO
Comments Off on Threats to Mankind from Drug Resistant Bacteria and Viruses
Are pharmaceutical mega-mergers in the public interest?
The main reason for governments around the world to encourage the pharmaceutical industry is to support Research and Development – R&D – with a view to the discovery of new drugs of future benefit to mankind. Commercial pharmaceutical companies have played … Continue reading
Posted in Business, competition, Drugs, Innovation, International, Pharma, Policy, Research, Technology
Tagged 2020health, AstraZeneca, Beecham, Boots, competition, David Jack, Drugs, Glaxo, innovation, Keith Mansford, medicine, merger, Pfizer, pharmaceutical, R&D, Research, Sir David Jack, SmithKline, Smithkline Beecham, Tagamet, takeover
Leave a comment
Medical advisory body “NICE” should not spend too much time valuing drugs.
The UK National Institute for Health and Care Excellence (“NICE”) is currently holding a public consultation over its proposals for evaluating drugs. Drugs that are approved by NICE automatically become available for doctors to prescribe under the NHS throughout England … Continue reading
Posted in Business, CCGs, Commissioning, Department of Health, Drugs, Elderly, equality, Genetics, GPs, Health and Wellbeing, Health Bill, Health reform, Inequality, Innovation, Jeremy Hunt, NHS, NHS reforms, Patients, Pharma, Policy, Public Health, Research, Technology, Uncategorized, Wellbeing
Tagged 2020health, Clinical Commissioning Group, Commissioning, Department of Health, dose, elderly, General practitioner, government, GP, GPs, health, Health Bill, innovation, Jeremy Hunt, medicine, Medicines and Healthcare products Regulatory Agency, MHRA, National Health Service, National Institute for Health and Care Excellence, NHS, NICE, Old age, patient, Patients, pharmaceutical, PPRS, pricing, Proportionate QALY, Public Health, QALY, R&D, Research, value-based, value-based pricing
Leave a comment
Guest Blogspot: Negotiations with the UK Government over pharmaceutical pricing have achieved a good result for patients, the NHS and the industry.
The UK Government and the pharmaceutical industry shared many objectives throughout the recent drug pricing negotiations. For example, there was always broad agreement that: The total future drug bill needed to be affordable in the context of other spending in … Continue reading
Posted in Andrew Lansley, Business, Cancer, Department of Health, Drugs, Innovation, Jeremy Hunt, NHS, Patients, Pharma, Research, Smoking ban
Tagged 2020health, Andrew Lansley, Department of Health, Drugs, government, innovation, Jeremy Hunt, National Health Service, NHS, NICE, parallel export, parallel imporrt, patient, Patient Access Scheme, Patients, pharmaceutical, PPRS, pricing, R&D, Research, value-based, value-based pricing, VBP
1 Comment
Access to orphan medicines: rare expertise and patient experience needs to be core part of decision
Blogpost by Leela Barham, Independent Health Economist and 2020health Research Fellow for Empower Access to Medicines Orphan medicines are used to treat some of the rarest conditions; conditions that affect less than 5 per 10,000 people in Europe. Some of … Continue reading
Guest Blogspot: Do private patients in the UK help or harm the NHS?
Private medicine like private education and first-class travel can stir up feelings of resentment between the “haves” and “have-nots”. A short blog like this one has no possibility of uniting stereotypical politicians from the left and right wings of politics. … Continue reading
Posted in Business, Department of Health, Drugs, Elderly, GPs, Health Bill, Health Team, Healthcare, Hospitals, Inequality, mental health, NHS, Nursing, Patient choice, Patients, Pharma, Policy, Private, Research
Tagged 2020health, choice, Consultant, Cosmetic Surgery, Dental, Department of Health, Drugs, elderly, Gamma Knife, General practitioner, government, GP, GPs, health, Health Bill, Medical Insurance, medicine, mental health, National Health Service, NHS, outcomes, patient, Patients, pharmaceutical, Prescription Charge, Private Hospital, Private Medicine, Private Patient, Research
Leave a comment
2020health's Blog 
You must be logged in to post a comment.